Attovia Therapeutics is a startup. 1 investor tracked.
Based in the United States, Attovia Therapeutics is a startup founded in 2018. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Attovia Therapeutics develops therapies for immune-mediated diseases using its proprietary ATTOBODY platform to create novel multispecific biologics that target multiple disease pathways within a single molecule.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.